Ingevity Corporation
NGVT
$69.66
-$1.98-2.76%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -23.42% | 12.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.42% | 12.76% | |||
| Cost of Revenue | -16.01% | 17.87% | |||
| Gross Profit | -34.43% | 5.93% | |||
| SG&A Expenses | -5.67% | 4.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.58% | 14.97% | |||
| Operating Income | -53.14% | 6.56% | |||
| Income Before Tax | -269.29% | 149.48% | |||
| Income Tax Expenses | -223.83% | 201.41% | |||
| Earnings from Continuing Operations | -293.14% | 130.72% | |||
| Earnings from Discontinued Operations | -314.81% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -294.48% | 129.69% | |||
| EBIT | -53.14% | 6.56% | |||
| EBITDA | -38.56% | 7.43% | |||
| EPS Basic | -297.79% | 129.78% | |||
| Normalized Basic EPS | -89.45% | 10.66% | |||
| EPS Diluted | -302.24% | 129.18% | |||
| Normalized Diluted EPS | -89.26% | 8.15% | |||
| Average Basic Shares Outstanding | -1.68% | -0.31% | |||
| Average Diluted Shares Outstanding | -3.40% | 1.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||